March 9, 2020 / 11:18 AM / a month ago

BRIEF-Almirall Says FDA Accepts The Filing Of The New Drug Application For Tirbanibulin

March 9 (Reuters) - Almirall SA:

* ANNOUNCES FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTANCE FOR FILING OF U.S. NEW DRUG APPLICATION (NDA) FOR TIRBANIBULIN IN ACTINIC KERATOSIS

* SAYS ESTIMATED PEAK SALES OF TIRBANIBULIN WILL BE IN EXCESS OF 250 MLN EUROS IN EUROPE AND IN THE US Source text: bit.ly/38DClwy Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below